Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aurobindo
Aurobindo
Teva, after Lupin deal, holds another Austedo generic challenger to a 2033 launch
Fierce Pharma
Sun, 06/12/22 - 08:19 pm
Teva Pharmaceutical
Austedo
generics
patents
tardive dyskinesia
Aurobindo
J&J takes Aurobindo to court over potential Erleada generic
Endpoints
Tue, 05/31/22 - 11:53 pm
JNJ
Aurobindo
legal
generics
Erleada
Aurobindo warned for lax investigations, repeat GMP violations
RAPS.org
Thu, 01/27/22 - 10:46 am
regulatory
FDA
Aurobindo
drug manufacturing
While Novartis combats generic onslaught in the courts, FDA approves first Gilenya copycats
Endpoints
Fri, 12/6/19 - 09:54 am
Novartis
FDA
Gilenya
MS
multiple sclerosis
Mylan
Dr Reddy's
Torrent Pharmaceuticals
Aurobindo
generics
Aurobindo is the Latest Company to Recall Ranitidine Medications
BioSpace
Sun, 11/10/19 - 07:50 pm
Aurobindo
ranitidine
product recalls
Manufacturing problems persist for Aurobindo, U.S.' second-largest generics producer
Fierce Pharma
Tue, 04/9/19 - 10:18 pm
Aurobindo
generics
Novartis
drug manufacturing
UnitedHealthcare, fueled by federal probes, sues generics makers for price fixing
Fierce Pharma
Tue, 01/22/19 - 11:48 am
UnitedHealthcare
generics
price fixing
drug pricing
Mylan
Teva Pharmaceuticals
Sandoz
Actavis
Par Pharmaceutical
Sun Pharma
Aurobindo
Taro Pharmaceuticals
Novartis sells parts of Sandoz for $1bn
Pharmaforum
Thu, 09/6/18 - 09:40 am
Novartis
Sandoz
M&A
dermatology
Aurobindo
List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape
GoinPharma
Mon, 05/14/18 - 09:32 am
Novartis
dermatology
generics
M&A
Aurobindo
Shanghai Fosun Pharmaceutical
Apollo Global Management
Aurobindo bids $1.6B for Novartis' U.S. dermatology generics: report
Fierce Pharma
Mon, 05/7/18 - 10:53 pm
Aurobindo
Novartis
Sandoz
M&A
dermatology
India
FDA Approves First Generic Versions of Amgen’s Sensipar
RAPS.org
Thu, 03/8/18 - 07:27 pm
FDA
generics
Amgen
Sensipar
Cipla
Aurobindo
Lilly's Strattera faces first wave of generic competition
BioPharma Dive
Fri, 06/2/17 - 11:31 am
Eli Lilly
Strattera
generics
ADHD
Apotex
Aurobindo
Glenmark
Teva Pharmaceutical
Golfing, ‘girls night out’ where pharma employees allegedly fixed prices
Stat
Fri, 12/23/16 - 09:59 am
generics
Aurobindo
Citron Pharma
Heritage Pharma
Teva
Mayne Pharma
Mylan
drug pricing
price fixing
price collusion
Recent FDA Approvals - Aug 15 2016
CP Wire
Mon, 08/15/16 - 03:50 pm
Aurobindo
Merck
FDA
drug approvals
Sun Pharma
Santarus
Keytruda
Boston Scientific
devices
Heron Therapeutics
Aurobindo Said to Enter Fray for $1.5 Billion Teva Portfolio
Bloomberg
Tue, 07/5/16 - 10:29 am
Aurobindo
Teva Pharmaceutical
M&A
UK
Ireland
Iceland
India
Actavis to Sell Some European Operations to Aurobindo Pharma
Bloomberg
Sat, 01/18/14 - 11:20 am
Actavis
Aurobindo
M&A
Aurobindo Pharma declares 'hidden' income
Times of India, India
Sun, 02/12/12 - 11:25 am
Aurobindo
India's Aurobindo Pharma posts 1Q loss
MarketWatch
Sat, 08/6/11 - 01:56 pm
Aurobindo
earnings
Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets
MedIndia, India
Sat, 06/11/11 - 02:36 pm
Aurobindo
ramipril
generics
Aurobindo Pharma Mulls Spinning Off Units
WSJ Online
Tue, 05/10/11 - 10:10 am
Aurobindo
Pages
1
2
next ›
last »